ReviewFrontiers in public health
A Review of COVID-19 Mass Testing in the United Arab Emirates.
Review in Frontiers in public health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Risk factors associated with mental health symptoms among health care workers during the COVID-19 pandemic in EMRO countries: a systematic review.BMC health services research · 2025Pooled it
- Strategies for the Prevention and Management of Respiratory Infections in Patients at High Risk in the UAE: A Cross-Disciplinary Position Paper.Pulmonary therapy · 2025Review
- Multi-sectoral collaborations in selected countries of the Eastern Mediterranean region: assessment, enablers and missed opportunities from the COVID-19 pandemic response.Health research policy and systems · 2024Article
- Mitigating healthcare worker risk during the COVID-19 pandemic - experience from a large tertiary maternity centre in the United Arab Emirates.Journal of medicine and life · 2023Article
- Diagnostic accuracy of Panbio™ rapid antigen test for SARS-CoV-2 in paediatric population.BMC pediatrics · 2023Article
- Serological Investigation on the Presence of Feline Coronavirus (FCoV) and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Domestic Cats Living with COVID-19 Positive Owners in the UAE, 2022.Animals : an open access journal from MDPI · 2023Article
- Article
- Modelling the effect of non-pharmaceutical interventions on COVID-19 transmission from mobility maps.Infectious Disease Modelling · 2022Article
- SARS-CoV-2 and COVID-19 Research Trend during the First Two Years of the Pandemic in the United Arab Emirates: A PRISMA-Compliant Bibliometric Analysis.International journal of environmental research and public health · 2022Article
- Article
- Heterogeneity in testing for infectious diseases.Royal Society open science · 2022Article
- Clinical and laboratory characteristics of patients hospitalised with COVID-19: clinical outcomes in Abu Dhabi, United Arab Emirates.BMC infectious diseases · 2022Article
- The Effect of COVID-19 Diagnosis on the Physical, Social, and Psychological Well-Being of People in the United Arab Emirates: An Explorative Qualitative Study.Frontiers in public health · 2022Article
- Peripheral blood cell anomalies in COVID-19 patients in the United Arab Emirates: A single-centered study.Frontiers in medicine · 2022Article
- The Impact of the COVID-19 "Infodemic" on Well-Being: A Cross-Sectional Study.Journal of multidisciplinary healthcare · 2022Article
- COVID-19 vaccine acceptance among healthcare workers in the United Arab Emirates.IJID regions · 2021Article
- The Middle East and COVID-19: time for collective action.Globalization and health · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Appropriate diagnostic testing to identify persons infected with SARS-COV-2 is a vital part of a health system's ability to control the global pandemic of COVID-19 disease. The primary purpose of this review is to provide an overview of the mass testing strategy implemented throughout the UAE and the overall impact it has made on containing and controlling the spread of the disease. This study describes the mass testing strategy and capacity of the UAE during the pandemic of the new coronavirus SARS-COV-2. The UAE has conducted 15 million polymerase chain reaction (PCR) tests to SARS-COV-2, as of 15 November 2020. The number of tests per day varied from 10,000 by the end of March to 120,000 tests per day in November 2020. The mass testing initiative across the entire UAE forms an integral part of a bigger strategy focusing on testing, tracing contacts and isolating positive cases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.